CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trials
Bell, Scott C, Barry, Peter J, De Boeck, Kris, Drevinek, Pavel, Elborn, J. Stuart, Plant, Barry J, Minić, Predag, Van Braeckel, Eva, Verhulst, Stijn, Muller, Karine, Kanters, Desirée, Bellaire, Susan, de Kock, Herman, Geller, David E, Conrath, Katja, Van de Steen, Olivier, van der Ent, Kors
Published in Journal of cystic fibrosis (01.09.2019)
Published in Journal of cystic fibrosis (01.09.2019)
Get full text
Journal Article
GLPG1837, a CFTR potentiator, in p.Gly551Asp (G551D)-CF patients: An open-label, single-arm, phase 2a study (SAPHIRA1)
Davies, Jane C, Van de Steen, Olivier, van Koningsbruggen-Rietschel, Silke, Drevinek, Pavel, Derichs, Nico, McKone, Edward F, Kanters, Desirée, Allamassey, Lisa, Namour, Florence, de Kock, Herman, Conrath, Katja
Published in Journal of cystic fibrosis (01.09.2019)
Published in Journal of cystic fibrosis (01.09.2019)
Get full text
Journal Article
Abstract 1790: BO-112 as a modifier of the tumor microenvironment for liver metastases
Quintero, Marisol, Pons, Vanesa, Maciá, Sonia, Rojas, María, López, Javier Sánchez, Kanters, Desiree, Escuin-Ordinas, Helena, Branum, Mark, Funes, Juan M., Pozuelo, Mercedes, Doherty, Mike
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article